Skip to main content
NCBI home page
Quality in Health Care : QHC logoLink to Quality in Health Care : QHC
. 1998 Jun;7(2):103–108. doi: 10.1136/qshc.7.2.103

Management of colorectal cancer

A Melville, T A Sheldon, R Gray, A Sowden
PMCID: PMC2483593  PMID: 10180789

Full Text

The Full Text of this article is available as a PDF (115.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam I. J., Mohamdee M. O., Martin I. G., Scott N., Finan P. J., Johnston D., Dixon M. F., Quirke P. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994 Sep 10;344(8924):707–711. doi: 10.1016/s0140-6736(94)92206-3. [DOI] [PubMed] [Google Scholar]
  2. Allen-Mersh T. G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994 Nov 5;344(8932):1255–1260. doi: 10.1016/s0140-6736(94)90750-1. [DOI] [PubMed] [Google Scholar]
  3. Allum W. H., Slaney G., McConkey C. C., Powell J. Cancer of the colon and rectum in the West Midlands, 1957-1981. Br J Surg. 1994 Jul;81(7):1060–1063. doi: 10.1002/bjs.1800810746. [DOI] [PubMed] [Google Scholar]
  4. Arblaster M. J., Collopy B. T., Elliott P. R., Mackay J. R., Ryan P. J., Woods R. J. Colonoscopy in a private hospital: continuous quality improvement in practice. Aust Clin Rev. 1992;12(2):71–76. [PubMed] [Google Scholar]
  5. Arbman G., Nilsson E., Hallbök O., Sjödahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg. 1996 Mar;83(3):375–379. doi: 10.1002/bjs.1800830326. [DOI] [PubMed] [Google Scholar]
  6. Audisio R. A., Setti-Carraro P., Segala M., Capko D., Andreoni B., Tiberio G. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol. 1996 Jul;3(4):349–357. doi: 10.1007/BF02305664. [DOI] [PubMed] [Google Scholar]
  7. Balslev I., Pedersen M., Teglbjaerg P. S., Hanberg-Soerensen F., Bone J., Jacobsen N. O., Overgaard J., Sell A., Bertelsen K., Hage E. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 1986 Jul 1;58(1):22–28. doi: 10.1002/1097-0142(19860701)58:1<22::aid-cncr2820580106>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  8. Brown M. L., Kessler L. G. Use of gene tests to detect hereditary predisposition to cancer: what do we know about cost effectiveness? Int J Cancer. 1996 Feb 20;69(1):55–57. doi: 10.1002/(SICI)1097-0215(19960220)69:1<55::AID-IJC14>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  9. Brown M. L., Nayfield S. G., Shibley L. M. Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. J Natl Cancer Inst. 1994 Mar 16;86(6):424–430. doi: 10.1093/jnci/86.6.424. [DOI] [PubMed] [Google Scholar]
  10. Bruinvels D. J., Stiggelbout A. M., Kievit J., van Houwelingen H. C., Habbema J. D., van de Velde C. J. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994 Feb;219(2):174–182. doi: 10.1097/00000658-199402000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Burns L. R., Wholey D. R. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care. 1991 Mar;29(3):251–271. doi: 10.1097/00005650-199103000-00007. [DOI] [PubMed] [Google Scholar]
  12. Buyse M., Zeleniuch-Jacquotte A., Chalmers T. C. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA. 1988 Jun 24;259(24):3571–3578. [PubMed] [Google Scholar]
  13. Cass O. W., Freeman M. L., Peine C. J., Zera R. T., Onstad G. R. Objective evaluation of endoscopy skills during training. Ann Intern Med. 1993 Jan 1;118(1):40–44. doi: 10.7326/0003-4819-118-1-199301010-00008. [DOI] [PubMed] [Google Scholar]
  14. Chang A. E., Schneider P. D., Sugarbaker P. H., Simpson C., Culnane M., Steinberg S. M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987 Dec;206(6):685–693. doi: 10.1097/00000658-198712000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Church J. M. Complete colonoscopy: how often? And if not, why not? Am J Gastroenterol. 1994 Apr;89(4):556–560. [PubMed] [Google Scholar]
  16. Clarke P. J., Dehn T. C., Kettlewell M. G. Changing patterns of colorectal cancer in a regional teaching hospital. Ann R Coll Surg Engl. 1992 Jul;74(4):291–293. [PMC free article] [PubMed] [Google Scholar]
  17. Cochrane J. P., Williams J. T., Faber R. G., Slack W. W. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. Br Med J. 1980 Mar 1;280(6214):593–595. doi: 10.1136/bmj.280.6214.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Collier B. D., Foley W. D. Current imaging strategies for colorectal cancer. J Nucl Med. 1993 Mar;34(3 Suppl):537–540. [PubMed] [Google Scholar]
  19. Crosland A., Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ. 1995 Aug 19;311(7003):486–488. doi: 10.1136/bmj.311.7003.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dahl O., Horn A., Morild I., Halvorsen J. F., Odland G., Reinertsen S., Reisaeter A., Kavli H., Thunold J. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer. 1990 Dec 1;66(11):2286–2294. doi: 10.1002/1097-0142(19901201)66:11<2286::aid-cncr2820661106>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  21. Darby C. R., Berry A. R., Mortensen N. Management variability in surgery for colorectal emergencies. Br J Surg. 1992 Mar;79(3):206–210. doi: 10.1002/bjs.1800790305. [DOI] [PubMed] [Google Scholar]
  22. Dixon A. R., Thornton-Holmes J., Cheetham N. M. General practitioners' awareness of colorectal cancer: a 10 year review. BMJ. 1990 Jul 21;301(6744):152–153. doi: 10.1136/bmj.301.6744.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Dunlop M., Campbell H. Screening for people with a family history of colorectal cancer. BMJ. 1997 Jun 21;314(7097):1779–1780. doi: 10.1136/bmj.314.7097.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Edelman M. J., Meyers F. J., Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997 May;12(5):318–331. doi: 10.1046/j.1525-1497.1997.012005318.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fijten G. H., Starmans R., Muris J. W., Schouten H. J., Blijham G. H., Knottnerus J. A. Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract. 1995 Sep;12(3):279–286. doi: 10.1093/fampra/12.3.279. [DOI] [PubMed] [Google Scholar]
  26. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D. L., Fisher E. R., Caplan R., Jones J., Lerner H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988 Mar 2;80(1):21–29. doi: 10.1093/jnci/80.1.21. [DOI] [PubMed] [Google Scholar]
  27. Flood A. B., Scott W. R., Ewy W. Does practice make perfect? Part I: The relation between hospital volume and outcomes for selected diagnostic categories. Med Care. 1984 Feb;22(2):98–114. [PubMed] [Google Scholar]
  28. Foster M. E., Hill J., Leaper D. J. Follow-up after colorectal cancer--current practice in Wales and south west England. Int J Colorectal Dis. 1987 Jun;2(2):118–119. doi: 10.1007/BF01647704. [DOI] [PubMed] [Google Scholar]
  29. Frykholm G. J., Glimelius B., Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993 Jun;36(6):564–572. doi: 10.1007/BF02049863. [DOI] [PubMed] [Google Scholar]
  30. Fuchs C. S., Giovannucci E. L., Colditz G. A., Hunter D. J., Speizer F. E., Willett W. C. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994 Dec 22;331(25):1669–1674. doi: 10.1056/NEJM199412223312501. [DOI] [PubMed] [Google Scholar]
  31. Goldberg P. A., Nicholls R. J., Porter N. H., Love S., Grimsey J. E. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer. 1994;30A(11):1602–1606. doi: 10.1016/0959-8049(94)00312-s. [DOI] [PubMed] [Google Scholar]
  32. Goodman D., Irvin T. T. Delay in the diagnosis and prognosis of carcinoma of the right colon. Br J Surg. 1993 Oct;80(10):1327–1329. doi: 10.1002/bjs.1800801037. [DOI] [PubMed] [Google Scholar]
  33. Goulston K. J., Cook I., Dent O. F. How important is rectal bleeding in the diagnosis of bowel cancer and polyps? Lancet. 1986 Aug 2;2(8501):261–265. doi: 10.1016/s0140-6736(86)92081-7. [DOI] [PubMed] [Google Scholar]
  34. Gérard A., Buyse M., Nordlinger B., Loygue J., Pène F., Kempf P., Bosset J. F., Gignoux M., Arnaud J. P., Desaive C. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg. 1988 Nov;208(5):606–614. doi: 10.1097/00000658-198811000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hakama M., Karjalainen S., Hakulinen T. Outcome-based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care. 1989;5(4):619–630. doi: 10.1017/s0266462300008497. [DOI] [PubMed] [Google Scholar]
  36. Hall C., Rowley S., Neoptolemos J. P. Anastomosis or stoma for low rectal cancer? Postgrad Med J. 1989 Mar;65(761):144–149. doi: 10.1136/pgmj.65.761.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hall N. R., Finan P. J., Ward B., Turner G., Bishop D. T. Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br J Surg. 1994 Oct;81(10):1485–1489. doi: 10.1002/bjs.1800811029. [DOI] [PubMed] [Google Scholar]
  38. Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
  39. Hardcastle J. D., Justin T. A. Screening high-risk groups for colorectal neoplasia. Am J Gastroenterol. 1996 May;91(5):850–852. [PubMed] [Google Scholar]
  40. Hawes R., Lehman G. A., Hast J., O'Connor K. W., Crabb D. W., Lui A., Christiansen P. A. Training resident physicians in fiberoptic sigmoidoscopy. How many supervised examinations are required to achieve competence? Am J Med. 1986 Mar;80(3):465–470. doi: 10.1016/0002-9343(86)90721-7. [DOI] [PubMed] [Google Scholar]
  41. Helfand M., Marton K. I., Zimmer-Gembeck M. J., Sox H. C., Jr History of visible rectal bleeding in a primary care population. Initial assessment and 10-year follow-up. JAMA. 1997 Jan 1;277(1):44–48. [PubMed] [Google Scholar]
  42. Hermanek P., Wiebelt H., Staimmer D., Riedl S. Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori. 1995 May-Jun;81(3 Suppl):60–64. [PubMed] [Google Scholar]
  43. Hodgson S. V., Bishop D. T., Dunlop M. G., Evans D. G., Northover J. M. Suggested screening guidelines for familial colorectal cancer. J Med Screen. 1995;2(1):45–51. doi: 10.1177/096914139500200112. [DOI] [PubMed] [Google Scholar]
  44. Hohn D. C., Stagg R. J., Friedman M. A., Hannigan J. F., Jr, Rayner A., Ignoffo R. J., Acord P., Lewis B. J. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989 Nov;7(11):1646–1654. doi: 10.1200/JCO.1989.7.11.1646. [DOI] [PubMed] [Google Scholar]
  45. Holliday H. W., Hardcastle J. D. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet. 1979 Feb 10;1(8111):309–311. doi: 10.1016/s0140-6736(79)90718-9. [DOI] [PubMed] [Google Scholar]
  46. Houlston R. S., Murday V., Harocopos C., Williams C. B., Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ. 1990 Aug 18;301(6748):366–368. doi: 10.1136/bmj.301.6748.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hulton N. R., Hargreaves A. W. Is long-term follow-up of all colorectal cancer necessary? J R Coll Surg Edinb. 1989 Feb;34(1):21–24. [PubMed] [Google Scholar]
  48. Hunt T. M., Flowerdew A. D., Birch S. J., Williams J. D., Mullee M. A., Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg. 1990 Jul;77(7):779–782. doi: 10.1002/bjs.1800770720. [DOI] [PubMed] [Google Scholar]
  49. Jones R. V., Dudgeon T. A. Time between presentation and treatment of six common cancers: a study in Devon. Br J Gen Pract. 1992 Oct;42(363):419–422. [PMC free article] [PubMed] [Google Scholar]
  50. Järvinen H. J., Mecklin J. P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995 May;108(5):1405–1411. doi: 10.1016/0016-5085(95)90688-6. [DOI] [PubMed] [Google Scholar]
  51. Kelly J. V., Hellinger F. J. Physician and hospital factors associated with mortality of surgical patients. Med Care. 1986 Sep;24(9):785–800. doi: 10.1097/00005650-198609000-00001. [DOI] [PubMed] [Google Scholar]
  52. Kemeny M. M., Goldberg D., Beatty J. D., Blayney D., Browning S., Doroshow J., Ganteaume L., Hill R. L., Kokal W. A., Riihimaki D. U. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer. 1986 Feb 1;57(3):492–498. doi: 10.1002/1097-0142(19860201)57:3<492::aid-cncr2820570315>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  53. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987 Oct;107(4):459–465. doi: 10.7326/0003-4819-107-4-459. [DOI] [PubMed] [Google Scholar]
  54. Kewenter J., Brevinge H., Engarås B., Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy. 1995 Feb;27(2):159–163. doi: 10.1055/s-2007-1005655. [DOI] [PubMed] [Google Scholar]
  55. Kievit J., Bruinvels D. J. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1222–1225. doi: 10.1016/0959-8049(95)00155-c. [DOI] [PubMed] [Google Scholar]
  56. Kim N. K., Senagore A. J., Luchtefeld M. A., MacKeigan J. M., Mazier W. P., Belknap K. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision? Am Surg. 1997 Jul;63(7):579–585. [PubMed] [Google Scholar]
  57. Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
  58. MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet. 1993 Feb 20;341(8843):457–460. doi: 10.1016/0140-6736(93)90207-w. [DOI] [PubMed] [Google Scholar]
  59. Macadam D. B. A study in general practice of the symptoms and delay patterns in the diagnosis of gastrointestinal cancer. J R Coll Gen Pract. 1979 Dec;29(209):723–729. [PMC free article] [PubMed] [Google Scholar]
  60. Malone D. E., McGrath F. P. Optimizing the detection of colorectal liver metastases within the Canadian health care system. Can Assoc Radiol J. 1993 Feb;44(1):5–13. [PubMed] [Google Scholar]
  61. Mameghan H., Gray B. N., de Zwart J., Richer R., Burns I., Hurley R., Ibister W. H., Reasbeck P., Newstead G. Adjuvant post-operative radiotherapy in rectal cancer: results from the ANZ Bowel Cancer Trial (Protocol 8202). Australas Radiol. 1991 Feb;35(1):61–65. doi: 10.1111/j.1440-1673.1991.tb02994.x. [DOI] [PubMed] [Google Scholar]
  62. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  63. Marsh P. J., James R. D., Schofield P. F. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum. 1994 Dec;37(12):1205–1214. doi: 10.1007/BF02257783. [DOI] [PubMed] [Google Scholar]
  64. Martin J. K., Jr, O'Connell M. J., Wieand H. S., Fitzgibbons R. J., Jr, Mailliard J. A., Rubin J., Nagorney D. M., Tschetter L. K., Krook J. E. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990 Aug;125(8):1022–1027. doi: 10.1001/archsurg.1990.01410200086013. [DOI] [PubMed] [Google Scholar]
  65. Maule W. F. Screening for colorectal cancer by nurse endoscopists. N Engl J Med. 1994 Jan 20;330(3):183–187. doi: 10.1056/NEJM199401203300307. [DOI] [PubMed] [Google Scholar]
  66. McArdle C. S., Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991 Jun 22;302(6791):1501–1505. doi: 10.1136/bmj.302.6791.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Melville A., Liberati A., Grilli R., Sheldon T. Management of primary breast cancer. Qual Health Care. 1996 Dec;5(4):250–258. doi: 10.1136/qshc.5.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Messori A., Bonistalli L., Costantini M., Trallori G., Tendi E. Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancer. J Clin Gastroenterol. 1996 Dec;23(4):269–274. doi: 10.1097/00004836-199612000-00006. [DOI] [PubMed] [Google Scholar]
  69. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993 Aug 25;270(8):943–947. [PubMed] [Google Scholar]
  70. Mäkelä J. T., Laitinen S. O., Kairaluoma M. I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg. 1995 Oct;130(10):1062–1067. doi: 10.1001/archsurg.1995.01430100040009. [DOI] [PubMed] [Google Scholar]
  71. Newcomb P. A., Norfleet R. G., Storer B. E., Surawicz T. S., Marcus P. M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992 Oct 21;84(20):1572–1575. doi: 10.1093/jnci/84.20.1572. [DOI] [PubMed] [Google Scholar]
  72. Ng I. O., Luk I. S., Yuen S. T., Lau P. W., Pritchett C. J., Ng M., Poon G. P., Ho J. Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer. 1993 Mar 15;71(6):1972–1976. doi: 10.1002/1097-0142(19930315)71:6<1972::aid-cncr2820710608>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  73. Niebel W., Schulz U., Ried M., Erhard J., Beersiek F., Blöcher G., Nier H., Halama H., Scherer E., Zeller G. Five-year results of a prospective and randomized study: experience with combined radiotherapy and surgery of primary rectal carcinoma. Recent Results Cancer Res. 1988;110:111–113. doi: 10.1007/978-3-642-83293-2_16. [DOI] [PubMed] [Google Scholar]
  74. Ohlsson B., Breland U., Ekberg H., Graffner H., Tranberg K. G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum. 1995 Jun;38(6):619–626. doi: 10.1007/BF02054122. [DOI] [PubMed] [Google Scholar]
  75. Parry B. R., Goh H. S. Quality control in colonoscopy: a Singapore perspective. Int J Colorectal Dis. 1993 Sep;8(3):139–141. doi: 10.1007/BF00341186. [DOI] [PubMed] [Google Scholar]
  76. Phillips R. K., Hittinger R., Blesovsky L., Fry J. S., Fielding L. P. Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg. 1984 Jan;71(1):12–16. doi: 10.1002/bjs.1800710104. [DOI] [PubMed] [Google Scholar]
  77. Poon M. A., O'Connell M. J., Wieand H. S., Krook J. E., Gerstner J. B., Tschetter L. K., Levitt R., Kardinal C. G., Mailliard J. A. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol. 1991 Nov;9(11):1967–1972. doi: 10.1200/JCO.1991.9.11.1967. [DOI] [PubMed] [Google Scholar]
  78. Pugliese V., Aste H., Saccomanno S., Bruzzi P., Bonelli L., Santi L. Outcome of follow-up programs in patients previously resected for colorectal cancer. Tumori. 1984 Apr 30;70(2):203–208. doi: 10.1177/030089168407000216. [DOI] [PubMed] [Google Scholar]
  79. Ratcliffe R., Kiff R. S., Kingston R. D., Walsh S. H., Jeacock J. Early diagnosis in colorectal cancer. Still no benefit? J R Coll Surg Edinb. 1989 Jun;34(3):152–155. [PubMed] [Google Scholar]
  80. Raymond J. M., Tissot B., Dartigues J. F., Capdenat Saint-Martin E., Vergier J. F., Michel P., Beyssac R., Salamon R., Amouretti M. Qualité des coloscopies réalisées en pratique courante dans la région Aquitaine. Gastroenterol Clin Biol. 1994;18(4):310–316. [PubMed] [Google Scholar]
  81. Reis Neto J. A., Quilici F. A., Reis J. A., Jr A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum. 1989 Aug;32(8):702–710. doi: 10.1007/BF02555778. [DOI] [PubMed] [Google Scholar]
  82. Rex D. K., Weddle R. A., Lehman G. A., Pound D. C., O'Connor K. W., Hawes R. H., Dittus R. S., Lappas J. C., Lumeng L. Flexible sigmoidoscopy plus air contrast barium enema versus colonoscopy for suspected lower gastrointestinal bleeding. Gastroenterology. 1990 Apr;98(4):855–861. doi: 10.1016/0016-5085(90)90007-n. [DOI] [PubMed] [Google Scholar]
  83. Rider W. D., Palmer J. A., Mahoney L. J., Robertson C. T. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg. 1977 Jul;20(4):335–338. [PubMed] [Google Scholar]
  84. Riedl S., Wiebelt H., Bergmann U., Hermanek P., Jr Postoperative Komplikationen und Letalität in der chirurgischen Therapie des Coloncarcinoms. Ergebnisse der deutschen Multizenterstudie der Studiengruppe Kolorektales Karzinom (SGKRK). Chirurg. 1995 Jun;66(6):597–606. [PubMed] [Google Scholar]
  85. Robinson E., Mohilever J., Zidan J., Sapir D. Colorectal cancer: incidence, delay in diagnosis and stage of disease. Eur J Cancer Clin Oncol. 1986 Feb;22(2):157–161. doi: 10.1016/0277-5379(86)90025-8. [DOI] [PubMed] [Google Scholar]
  86. Robinson M. H., Thomas W. M., Hardcastle J. D., Chamberlain J., Mangham C. M. Change towards earlier stage at presentation of colorectal cancer. Br J Surg. 1993 Dec;80(12):1610–1612. doi: 10.1002/bjs.1800801241. [DOI] [PubMed] [Google Scholar]
  87. Rozen P., Ron E. A cost analysis of screening methodology for family members of colorectal cancer patients. Am J Gastroenterol. 1989 Dec;84(12):1548–1551. [PubMed] [Google Scholar]
  88. Sagar P. M., Hartley M. N., MacFie J., Taylor B. A., Copeland G. P. Comparison of individual surgeon's performance. Risk-adjusted analysis with POSSUM scoring system. Dis Colon Rectum. 1996 Jun;39(6):654–658. doi: 10.1007/BF02056945. [DOI] [PubMed] [Google Scholar]
  89. Scheithauer W., Rosen H., Kornek G. V., Sebesta C., Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 1993 Mar 20;306(6880):752–755. doi: 10.1136/bmj.306.6880.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Selby J. V., Friedman G. D., Quesenberry C. P., Jr, Weiss N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992 Mar 5;326(10):653–657. doi: 10.1056/NEJM199203053261001. [DOI] [PubMed] [Google Scholar]
  91. Smith R. D., Hall J., Gurney H., Harnett P. R. A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma. Med J Aust. 1993 Mar 1;158(5):319–322. doi: 10.5694/j.1326-5377.1993.tb121787.x. [DOI] [PubMed] [Google Scholar]
  92. Sprangers M. A., Taal B. G., Aaronson N. K., te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum. 1995 Apr;38(4):361–369. doi: 10.1007/BF02054222. [DOI] [PubMed] [Google Scholar]
  93. St John D. J., McDermott F. T., Hopper J. L., Debney E. A., Johnson W. R., Hughes E. S. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993 May 15;118(10):785–790. doi: 10.7326/0003-4819-118-10-199305150-00005. [DOI] [PubMed] [Google Scholar]
  94. Stevenson G. Radiology in the detection and prevention of colorectal cancer. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1121–1126. doi: 10.1016/0959-8049(95)00230-g. [DOI] [PubMed] [Google Scholar]
  95. Stubbs R. S., Long M. G. Symptom duration and pathologic staging of colorectal cancer. Eur J Surg Oncol. 1986 Jun;12(2):127–130. [PubMed] [Google Scholar]
  96. Thomas P. R., Lindblad A. S. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol. 1988 Dec;13(4):245–252. doi: 10.1016/0167-8140(88)90219-8. [DOI] [PubMed] [Google Scholar]
  97. Treurniet-Donker A. D., van Putten W. L., Wereldsma J. C., Bruggink E. D., Hoogenraad W. J., Roukema J. A., Snijders-Keilholz A., Meijer W. S., Meerwaldt J. H., Wijnmaalen A. J. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1991 Apr 15;67(8):2042–2048. doi: 10.1002/1097-0142(19910415)67:8<2042::aid-cncr2820670806>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  98. Törnqvist A., Ekelund G., Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg. 1982 Dec;69(12):725–728. doi: 10.1002/bjs.1800691213. [DOI] [PubMed] [Google Scholar]
  99. Vernava A. M., 3rd, Longo W. E., Virgo K. S., Coplin M. A., Wade T. P., Johnson F. E. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1994 Jun;37(6):573–583. doi: 10.1007/BF02050993. [DOI] [PubMed] [Google Scholar]
  100. Virgo K. S., Vernava A. M., Longo W. E., McKirgan L. W., Johnson F. E. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995 Jun 21;273(23):1837–1841. [PubMed] [Google Scholar]
  101. Walker A. R., Whynes D. K., Chamberlain J. O., Hardcastle J. D. The hospital costs of diagnostic procedures for colorectal cancer. J Clin Epidemiol. 1991;44(9):907–914. doi: 10.1016/0895-4356(91)90053-c. [DOI] [PubMed] [Google Scholar]
  102. Winawer S. J., Fletcher R. H., Miller L., Godlee F., Stolar M. H., Mulrow C. D., Woolf S. H., Glick S. N., Ganiats T. G., Bond J. H. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997 Feb;112(2):594–642. doi: 10.1053/gast.1997.v112.agast970594. [DOI] [PubMed] [Google Scholar]
  103. Zerhouni E. A., Rutter C., Hamilton S. R., Balfe D. M., Megibow A. J., Francis I. R., Moss A. A., Heiken J. P., Tempany C. M., Aisen A. M. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology. 1996 Aug;200(2):443–451. doi: 10.1148/radiology.200.2.8685340. [DOI] [PubMed] [Google Scholar]

Articles from Quality in Health Care : QHC are provided here courtesy of BMJ Publishing Group

RESOURCES